Fortress Biotech, Inc. (FBIO) › Cost of RevenueFortress Biotech, Inc. (FBIO) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2017: $3.66M2018: $6.12M2019: $10.53M2020: $14.59M2021: $32.08M2022: $30.77M2023: $22.89M2024: $20.88M2025: $20.92M$20.92M2017Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$20.92M+0.2%2024$20.88M-8.8%2023$22.89M-25.6%2022$30.77M-4.1%2021$32.08M+119.8%2020$14.59M+38.6%2019$10.53M+72.0%2018$6.12M+67.4%2017$3.66M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share